Elena Hartmann-Gerhard

Josef Schneider Str. 4
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

The human trophoblast cell-surface antigen 2 (TROP-2) expression on metastasized breast cancer.

The human trophoblast cell-surface antigen 2 (TROP-2) expression on metastasized breast cancer.

Journal: Journal of cancer research and clinical oncology

Published: March 23, 2026

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

Journal: Leukemia

Published: December 06, 2025

Targeted panel sequencing for refining B-cell lymphoma diagnosis: a real-life, reference center experience.

Targeted panel sequencing for refining B-cell lymphoma diagnosis: a real-life, reference center experience.

Journal: Virchows Archiv : an international journal of pathology

Published: October 30, 2025

Diagnostic Performance of Somatostatin Receptor-directed PET/CT for Tumor-induced Osteomalacia.

Diagnostic Performance of Somatostatin Receptor-directed PET/CT for Tumor-induced Osteomalacia.

Journal: Molecular imaging and biology

Published: September 22, 2025

Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma.

Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma.

Journal: Haematologica

Published: September 11, 2025

Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.

Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy.

Journal: Leukemia

Published: August 15, 2025

Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer.

Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer.

Journal: JCO precision oncology

Published: August 06, 2025

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.

Journal: Leukemia

Published: August 06, 2025

Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritis.

Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritis.

Journal: Arthritis research & therapy

Published: July 08, 2025

Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology.

Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology.

Journal: Frontiers in oncology

Published: March 02, 2025

Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma.

Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 27, 2025

Fibrin-associated large B-cell lymphoma arising in a cystic lymphangiomatous lesion of the adrenal gland: A case report and overview of the entity.

Fibrin-associated large B-cell lymphoma arising in a cystic lymphangiomatous lesion of the adrenal gland: A case report and overview of the entity.

Journal: Pathology, research and practice

Published: January 22, 2025

Showing 1-12 of 42

Last Updated: 09/26/2026